Coherus Oncology Inc (CHRS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CHRS? Forum Prognose

Finanzdaten der Coherus Oncology Inc-Aktie (CHRS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.17% 12.75	11.57	10.25	7.599	54.14
Cost Of Revenue	8.71% 4.045	3.721	3.395	2.653	33.86
Gross Profit	10.87% 8.703	7.85	6.859	4.946	20.29
Operating Expenses	4.60% 54.58	52.18	52.34	50.38	62.53
Interest Income/Expense	3.27% 2.249	2.325	2.277	2.15	5.346
Benefits Costs and Expenses	5.36% 59.09	56.09	55.12	55.00	104.84
Costs And Expenses	4.87% 58.63	55.90	55.74	53.03	96.39
Depreciation and Amortization	7.25% 0.896	0.966	1.016	1.046	1.033
Operating Income/Loss	3.49% -45.88	-44.33	-45.49	-45.44	-42.25
Income/Loss From Continuing Operations Before Tax	4.11% -46.35	-44.52	-44.86	-47.40	-50.70
Income/Loss From Continuing Operations After Tax	4.11% -46.35	-44.52	-44.86	-47.40	-50.70
Income/Loss From Discontinued Operations, Net Of Tax	3.14% 8.704	8.986	342.63	-9.171	-
Net Income/Loss	5.94% -37.64	-35.53	297.77	-56.57	-50.70
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.06% 1.0872	116.23	116.08	115.86	0.2903
Diluted Average Shares	99.06% 1.0872	116.23	116.08	115.86	-11.73
Basic Earnings Per Share	9.68% -0.34	-0.31	2.57	-0.49	-0.44
Diluted Earnings Per Share	9.68% -0.34	-0.31	2.57	-0.49	-0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%